Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Construction in Progress: 2011-2016

Historic Construction in Progress for Anika Therapeutics (ANIK) over the last 6 years, with Dec 2016 value amounting to $22.7 million.

  • Anika Therapeutics' Construction in Progress rose 101.30% to $22.7 million in Q4 2016 from the same period last year, while for Dec 2016 it was $22.7 million, marking a year-over-year increase of 101.30%. This contributed to the annual value of $22.7 million for FY2016, which is 101.30% up from last year.
  • Anika Therapeutics' Construction in Progress amounted to $22.7 million in FY2016, which was up 101.30% from $11.3 million recorded in FY2015.
  • Over the past 5 years, Anika Therapeutics' Construction in Progress peaked at $22.7 million during FY2016, and registered a low of $42,270 during FY2012.
  • For the 3-year period, Anika Therapeutics' Construction in Progress averaged around $11.5 million, with its median value being $11.3 million (2015).
  • In the last 5 years, Anika Therapeutics' Construction in Progress tumbled by 99.84% in 2012 and then soared by 1,916.82% in 2015.
  • Over the past 5 years, Anika Therapeutics' Construction in Progress (Yearly) stood at $42,270 in 2012, then skyrocketed by 272.11% to $157,292 in 2013, then skyrocketed by 255.39% to $559,000 in 2014, then surged by 1,916.82% to $11.3 million in 2015, then soared by 101.30% to $22.7 million in 2016.